Author

Maryam Ebadi

Institution: Hamedan University of Medical Sciences

Observed institution: Hamedan University of Medical Sciences

OpenAlex ID: A5154935585

Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.

2026 · Sajjad Daneshyar, Masoud Ghiasian, et al. · PubMed Central

Works count: 1

Citation count:

H-index:

I10-index: